Conexeu's B.R.E.A.S.T.™ was developed using the Company's proprietary CXU™ regenerative tissue platform to support gradual ...
Data demonstrate distinct functional signatures across MSC-derived extracellular vesicles supporting targeted regenerative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results